MetLife Investment Management, LLC - CYTOSORBENTS CORP ownership

CYTOSORBENTS CORP's ticker is CTSO and the CUSIP is 23283X206. A total of 97 filers reported holding CYTOSORBENTS CORP in Q3 2020. The put-call ratio across all filers is 1.36 and the average weighting 0.1%.

Quarter-by-quarter ownership
MetLife Investment Management, LLC ownership history of CYTOSORBENTS CORP
ValueSharesWeighting
Q3 2021$125,243
-18.4%
15,424
-12.8%
0.00%0.0%
Q1 2021$153,480
+28.6%
17,682
+18.1%
0.00%0.0%
Q4 2020$119,359
-0.1%
14,9760.0%0.00%0.0%
Q3 2020$119,434
-19.4%
14,9760.0%0.00%
-50.0%
Q2 2020$148,262
+32.5%
14,976
+1.3%
0.00%
+100.0%
Q1 2019$111,922
-6.3%
14,7850.0%0.00%0.0%
Q4 2018$119,463
-37.4%
14,7850.0%0.00%
-50.0%
Q3 2018$190,727
+12.9%
14,7850.0%0.00%0.0%
Q2 2018$169,00014,7850.00%
Other shareholders
CYTOSORBENTS CORP shareholders Q3 2020
NameSharesValueWeighting ↓
Sargent Investment Group, LLC 692,738$5,524,0002.01%
Skylands Capital, LLC 1,421,700$11,345,0001.89%
SECTORAL ASSET MANAGEMENT INC 1,629,989$12,999,0001.12%
Winning Points Advisors, LLC 286,200$1,142,990,0000.97%
Redmile Group, LLC 2,101,131$16,757,0000.31%
Granahan Investment Management 632,035$5,040,0000.17%
Avenir Corp 190,240$1,517,0000.16%
Seelaus Asset Management LLC 20,000$160,0000.13%
Olympiad Research LP 17,816$142,0000.07%
HighMark Wealth Management LLC 10,000$80,0000.07%
View complete list of CYTOSORBENTS CORP shareholders